Innovative Drug Concept Stocks Surge: Tianjin Kingyork Pharmaceuticals Secures Six Consecutive Daily Limit-Ups
4 day ago / Read about 0 minute
Author:小编   

The innovative drug concept stocks have demonstrated remarkable strength in the market, with Tianjin Kingyork Pharmaceuticals hitting the daily limit for six consecutive trading days. Meanwhile, Chongqing Pharmaceutical Holding has achieved two consecutive daily limit-ups, with individual stocks like Laimei Pharmaceutical, Shuanglu Pharmaceutical, and Yibai Pharmaceutical also following the upward trend. However, Tianjin Kingyork Pharmaceuticals has clarified that it currently has no innovative drug projects under research and has reminded investors to remain vigilant about potential risks.